Delta‐Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma

PURPOSE: Delta‐like protein 3 (DLL3) is being developed as a predictive biomarker for DLL3‐targeting antibody‐drug conjugate and other therapies. Given the neuroendocrine features of Merkel cell carcinoma (MCC), we sought to evaluate DLL3 expression and its role in MCC. EXPERIMENTAL DESIGN: Formalin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Xie, Hao, Kaye, Frederic J., Isse, Kumiko, Sun, Yan, Ramoth, Johanna, French, Dorothy M., Flotte, Thomas J., Luo, Yan, Saunders, Laura R., Mansfield, Aaron S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Melanoma and Cutaneous Malignancies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485334/
https://ncbi.nlm.nih.gov/pubmed/32372416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0877
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars